Pharmaceutical Excipients Market Performance and Future Outlook at 6.1% CAGR Through 2029

Global Anemia And Other Blood Disorder Drugs Market

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceutical excipients market from 2025–2034 with trusted insights from The Business Research Company

What Is The Predicted Size Of The Pharmaceutical Excipients Industry By 2029?

The anemia and other blood disorder drugs market size has experienced strong growth in recent years. It is expected to expand from $11.81 billion in 2024 to $12.46 billion in 2025, progressing at a compound annual growth rate (CAGR) of 5.5%. This historical growth can be attributed to factors such as disease prevalence, global health initiatives, an aging population, pharmaceutical innovation, and patient awareness.

The anemia and other blood disorder drugs market size is anticipated to undergo significant expansion in the coming years. It is forecast to increase to $15.82 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.1%. The expansion during the projected period can be attributed to factors such as emerging markets, global demographic shifts, and various economic considerations. Noteworthy trends for the forecast period include continued research and development, ongoing technological advances, the emergence of biologics and targeted therapies, the development of gene therapies, the implementation of telemedicine and remote monitoring, the granting of orphan drug designations, and a prevalence of mergers and acquisitions.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2465&type=smp

What Major Drivers Are Impacting The Pharmaceutical Excipients Market?

The global market is significantly propelled by the rising incidence of anemia across the world’s population. Poor lifestyle choices, shifting dietary patterns, and heightened stress levels have led to a global rise in anemia cases. For example, anemia is recognized as the most common ailment among individuals over 65 years old, with its prevalence reaching approximately 17%. Furthermore, the World Bank indicated that anemia stands as the 8th primary cause of illness among women and younger demographics. This escalating prevalence of anemia directly fuels the anemia and other blood disorder drugs market.

Which Segment Categories Are Driving Maximum Growth In The Pharmaceutical Excipients Market?

The anemia and other blood disorder drugs market covered in this report is segmented –

1) By Type: Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia

2) By Route of Administration: Oral, Injectable

3) By Distribution Channel: Hospitals Pharmacy, Online Pharmacy, Pharmacy

Subsegments:

1) By Iron Deficiency Anemia: Oral Iron Supplements, Injectable Iron Supplements, Iron Fortified Foods

2) By Chronic Kidney Disease Anemia: Erythropoiesis-Stimulating Agents (ESAs), Iron Supplements, Blood Transfusion

3) By Sickle Cell Anemia: Hydroxyurea, Blood Transfusions, Gene Therapy, Pain Management Drugs

4) By Aplastic Anemia: Immunosuppressive Therapy, Stem Cell Transplantation, Erythropoiesis-Stimulating Agents (ESAs)

Which Long-Term Trends Will Play A Crucial Role In The Pharmaceutical Excipients Market?

Entities within the anemia and other blood disorder drugs market are forging partnerships with government bodies to advance the development and commercialization of specific medications through shared knowledge, technology, and financial resources. These collaborations are additionally beneficial for companies, particularly when confronting expiring licenses and a stringent regulatory environment. For example, in March 2023, Disc Medicine announced a collaboration with the National Institutes of Health (NIH) and the National Heart, Lung, and Blood Institute (NHLBI) to conduct Phase 1/2 and Phase 2 clinical trials of biopterin for patients with Diamond-Blackfan Anemia (DBA), with the aim of treating adult patients experiencing iron deficiency anemia. The NIH will be responsible for conducting and funding these studies under a cooperative research and development agreement (CRADA).

Who Are The Dominant Players In The Pharmaceutical Excipients Market Today?

Major companies operating in the anemia and other blood disorder drugs market include Amgen Inc, GlaxoSmithKline plc, Akebia Therapeutics Inc., Bayer AG, Pfizer Inc, F. Hoffmann-La Roche Ltd., Merck Sharp & Dohme Corp., Novartis AG, Global Blood Therapeutics Inc., GlycoMimetics Inc., Eli Lilly and Company, FibroGen Inc., bluebird bio Inc., Acceleron Pharma Inc., AMAG Pharmaceuticals Inc., Pieris Pharmaceuticals Inc., Vifor Pharma Management Ltd., Sanofi S.A., Allergan U.S. Inc., Meda Consumer Healthcare Inc., AbbVie Inc., Johnson & Johnson, Daiichi Sankyo Company Limited, Galenica Ltd., Pharmacosmos A/S, Emmaus Medical Inc., Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb Company, Merck & Co. Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., uniQure N.V., Rubius Therapeutics Inc., BioMarin Pharmaceutical Inc., Grifols S.A., Orchard Therapeutics plc

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Which Region Is At The Forefront Of Innovation In The Pharmaceutical Excipients Market?

North America was the largest region in the anemia and other blood disorder drugs market in 2024. Middle East is expected to be the fastest-growing region in the anemia and other blood disorder drugs market during the forecast period. The regions covered in the anemia and other blood disorder drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2465&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Excipients Market 2025, By The Business Research Company

Anti Infective Drugs Market 2025

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Hospital Acquired Infections Testing Kits Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Anti Viral Drug Therapy Market 2025

https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model